Cuiheng Group on August 22 conducted an investment promotion and exchange conference, during which it signed 15 projects covering biomedicine, high-end equipment, electronic information, services and other industries.

Among the newly signed, the research and manufacturing base for high-end electronic magnetic components is invested by innovative high-tech enterprise Lianzhen Electronics. The company's products are widely used in such fields as AI and big data computing, computer motherboard making, communication and networking. The project costs about one billion yuan and is expected to generate an annual output value of 1.2 billion yuan at its full capacity.

Most of the new projects target the biomedicine industry, including LKSD's bio-pharmaceutical CDMO project, the Small Molecular Innovative Drug for Hematological Tumor project, the DC Cell Therapy Vaccine R&D project, Laibai's animal detection platform project, and Novastage's transdermal patch production project.

There are five services projects, including Yum China, McDonald's, Dashenlin and XKD projects and the Bay Community Supporting Facilities for Residents project.

The conference also showcased prestigious industrial platforms to the public, including the Zhongshan Life Science Park, the CHIS Park and the Cuiheng International Technology Innovation Center.